Stay updated on PI3K/Akt Suppression vs MK-3475 in Glioblastoma Clinical Trial
Sign up to get notified when there's something new on the PI3K/Akt Suppression vs MK-3475 in Glioblastoma Clinical Trial page.
Latest updates to the PI3K/Akt Suppression vs MK-3475 in Glioblastoma Clinical Trial page
- Check3 days agoChange DetectedThe website has updated the intervention details to include a verified status by Ms. Jann Lee and has moved to revision v2.14.0, while the previous type of intervention has been removed.SummaryDifference0.9%
- Check10 days agoNo Change Detected
- Check17 days agoNo Change Detected
- Check24 days agoNo Change Detected
- Check32 days agoChange DetectedThe website has been updated from version 2.13.2 to 2.13.3.SummaryDifference0.1%
- Check39 days agoChange DetectedThe website has updated the contact details section for the study, clarifying that it now provides information for individuals who can answer questions about joining the study and includes a reference to the Contacts and Locations section.SummaryDifference3%
- Check53 days agoChange DetectedSeveral links related to rare diseases and clinical trials have been removed, including those for glioblastoma and glioma, as well as resources from NIH and Dailymed.SummaryDifference4%
- Check61 days agoChange DetectedNew resources related to rare diseases and treatment options, including specific links for glioblastoma, gliosarcoma, glioma, and neuroepithelioma, have been added, along with links to major health and government websites.SummaryDifference0.5%
- Check68 days agoChange DetectedThe website has been updated to version v2.12.2, introducing new features for downloading data in various formats and allowing users to select specific fields for export.SummaryDifference4%
Stay in the know with updates to PI3K/Akt Suppression vs MK-3475 in Glioblastoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the PI3K/Akt Suppression vs MK-3475 in Glioblastoma Clinical Trial page.